Back |
home / stock / kool / kool message board
Subject | By | Source | When |
---|---|---|---|
Above .50 now Kaboom Baybeee! $$$$ 1.00 then | ALL-IN888 | investorshub | 08/30/2018 2:26:01 PM |
High Tight Ascending Flag pattern Fun begins above | ALL-IN888 | investorshub | 08/30/2018 2:22:08 PM |
Weekly Target is @ 2.00 - 2.10 BOOM!!! $$$ | ALL-IN888 | investorshub | 08/30/2018 1:56:44 PM |
Loaded more from .4699 Fun begins above .47 $$$ | ALL-IN888 | investorshub | 08/30/2018 1:48:45 PM |
Gap being filled @ .465 - .47 Lets | ALL-IN888 | investorshub | 08/30/2018 1:44:56 PM |
ALL @ .47 Lets Explode it back to | ALL-IN888 | investorshub | 08/30/2018 1:40:36 PM |
next wall .58 to .62 we should see | AugustaFriends | investorshub | 08/30/2018 12:35:32 PM |
I got me 25K shares at .255 | AugustaFriends | investorshub | 08/30/2018 12:35:08 PM |
Finally, been waiting on this one a while lol | Screech691 | investorshub | 08/30/2018 12:29:22 PM |
at .46 break we should see .52 to | AugustaFriends | investorshub | 08/30/2018 12:11:32 PM |
Next wall based on charts is .58 to .62 | AugustaFriends | investorshub | 08/30/2018 12:08:46 PM |
Good morning All | AugustaFriends | investorshub | 08/30/2018 12:08:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Cesca Therapeutics Inc. Company Name:
KOOL Stock Symbol:
NASDAQ Market:
Cesca Therapeutics Inc. Website:
RANCHO CORDOVA, Calif. , Oct. 31, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis") in order...
RANCHO CORDOVA, Calif. , Oct. 24, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Chris Xu , Ph.D., Chairman and Chief Executive Officer, will present a...
RANCHO CORDOVA, Calif. , Oct. 22, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary, today announced that the company...